70–95% (densitometry)
References
1. Hajdo-Milasinovic, A. et al., Rac3 inhibits adhesion
and differentiation of neuronal cells by modifying
GIT1 downstream signaling. J. Cell Sci.,
122(Pt 12)
Temperature Bag transfer system: -20 to 50 °C (-4 to 122
°F). Tube transfer system: Polyethylene: -20 to
50 °C (-4 to 122 °F); Silicone: -50 to 95 °C (-58 to
203 °F), C-Flex®: -73 to 132 °C (-99 to
50 ml € 122
PhosphoDetect™ Anti-MAPKAPK-2 (pThr222)
Rabbit pAb
PK1007 Protein A and immunoaffinity purified. Recognizes the ~47 kDa MAP kinase-
activated protein kinase 2 (MAPKAPK-2) protein phosphorylated
overexpression in
Escherichia coli of the gene, and characteristics of
the enzyme. J. Biochem., 122, 843-850 (1997).
2. Bradshaw, R.A., et al., N-terminal processing: the
methionine aminopeptidase and N alpha-acetyl
insight into the intermolecular
interactions of the gp41 loop. Biochim. Biophys.
Acta., 1536, 116−122 (2001).
2. Caffrey, M., et al., Biophysical characterization of
gp41 aggregates suggests a model for the
soluble in 95% ethanol (50 mg/ml),
yielding a clear faint yellow solution. Heat may be
required to get it to dissolve at that concentration.
References
1. The Merck Index, 11th ed., Entry# 4011.
2. J.
form a DNA cleavable complex, induce thymocyte
apoptosis. Biochem. Mol. Biol. Int., 32, 115-122
(1994).
2. Yoshida, M., et al., MST-16, a novel Bis-
dioxopiperazine anticancer agent, ameliorates
doxorubicin-induced
activating caspases and down-regulating
survivin. Purity: ≥95% by HPLC. M.W. 422.5
N
NN
H
N
H
NN
O O
Cat. No. 238804 5 mg € 122
Ref.: Pennati, M., et al. 2005. Mol. Cancer Ther. 4
Operating
Temperature
Tube transfer system: Polyethylene: -20
to 50°C (-4 to 122°F); Silicone: -50 to
95°C (-58 to 203°F), C-Flex®: -73 to
132°C (-99 to 270°F)
Traceability The packaging
, and Zerial, M., Curr. Opin. Cell Biol., 9,
496-504 (1997).
2. Geppert, M., and Sudhof, T. C., Annu. Rev.
Neurosci., 21, 75-95 (1998).
3. Novick, P., and Zerial, M., Curr. Opin. Cell. Biol.
Cano, E., and Mehavedan, L.C., TIBS, 20,
117-122 (1995).
2. Seger, R., and Krebs, E., FASEB J., 9, 726-735
(1995).
3. Nebreda, A. N., TIBS, 19, 1-2 (1994).
4. Ward, Y. et
REFERENCES:
1. Cannella, M. and Ross, R. (1987). Experimental Neurology 95:652-660.
2. Foster, R. et al. (1987). Developmental Biology 122:11-20.
3. Grant, P. and Tseng, Y. (1986). Developmental Biology 114
binding, and
biological properties of the glycosylated
and nonglycosylated forms. Endocrinology,
122, 2667–2674 (1988).
5. Lewis, U.J. et al., Two forms of glycosylated human
prolactin have different
mM PMSF, and 25%
glycerol.
Molecular mass: ∼122 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 42–58 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is